Medical - Healthcare Information Services
Compare Stocks
4 / 10Stock Comparison
BTSG vs LFST vs ACHC vs ENSG
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Medical - Care Facilities
Medical - Care Facilities
BTSG vs LFST vs ACHC vs ENSG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Healthcare Information Services | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities |
| Market Cap | $10.23B | $3.43B | $2.25B | $10.18B |
| Revenue (TTM) | $13.65B | $1.49B | $3.37B | $5.27B |
| Net Income (TTM) | $310M | $23M | $-1.11B | $363M |
| Gross Margin | 12.2% | 21.7% | 56.2% | 15.2% |
| Operating Margin | 3.3% | 3.0% | 11.7% | 8.5% |
| Forward P/E | 34.0x | 121.1x | 16.4x | 23.2x |
| Total Debt | $2.84B | $194M | $2.65B | $4.15B |
| Cash & Equiv. | $88M | $249M | $133M | $504M |
BTSG vs LFST vs ACHC vs ENSG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jan 24 | May 26 | Return |
|---|---|---|---|
| BrightSpring Health… (BTSG) | 100 | 480.4 | +380.4% |
| LifeStance Health G… (LFST) | 100 | 148.0 | +48.0% |
| Acadia Healthcare C… (ACHC) | 100 | 29.8 | -70.2% |
| The Ensign Group, I… (ENSG) | 100 | 153.9 | +53.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BTSG vs LFST vs ACHC vs ENSG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BTSG is the #2 pick in this set and the best alternative if growth exposure and valuation efficiency is your priority.
- Rev growth 14.6%, EPS growth 10.3%, 3Y rev CAGR 18.7%
- PEG 0.70 vs ENSG's 1.68
- PEG 0.70 vs 1.68
- +129.8% vs ACHC's +1.2%
LFST is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 1.20, Low D/E 12.8%, current ratio 1.65x
- Beta 1.20, current ratio 1.65x
ACHC lags the leaders in this set but could rank higher in a more targeted comparison.
ENSG carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 12 yrs, beta 0.42, yield 0.1%
- 7.5% 10Y total return vs BTSG's 381.3%
- 18.7% revenue growth vs ACHC's 5.0%
- 6.9% margin vs ACHC's -32.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.7% revenue growth vs ACHC's 5.0% | |
| Value | PEG 0.70 vs 1.68 | |
| Quality / Margins | 6.9% margin vs ACHC's -32.8% | |
| Stability / Safety | Beta 0.42 vs BTSG's 1.46 | |
| Dividends | 0.1% yield; 12-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +129.8% vs ACHC's +1.2% | |
| Efficiency (ROA) | 6.8% ROA vs ACHC's -18.6%, ROIC 7.0% vs 5.9% |
BTSG vs LFST vs ACHC vs ENSG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BTSG vs LFST vs ACHC vs ENSG — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ACHC leads in 1 of 6 categories
BTSG leads 1 • ENSG leads 1 • LFST leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — BTSG and ACHC each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BTSG is the larger business by revenue, generating $13.6B annually — 9.1x LFST's $1.5B. ENSG is the more profitable business, keeping 6.9% of every revenue dollar as net income compared to ACHC's -32.8%. On growth, BTSG holds the edge at +25.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $13.6B | $1.5B | $3.4B | $5.3B |
| EBITDAEarnings before interest/tax | $572M | $100M | $588M | $558M |
| Net IncomeAfter-tax profit | $310M | $23M | -$1.1B | $363M |
| Free Cash FlowCash after capex | $508M | $179M | -$215M | $406M |
| Gross MarginGross profit ÷ Revenue | +12.2% | +21.7% | +56.2% | +15.2% |
| Operating MarginEBIT ÷ Revenue | +3.3% | +3.0% | +11.7% | +8.5% |
| Net MarginNet income ÷ Revenue | +2.3% | +1.6% | -32.8% | +6.9% |
| FCF MarginFCF ÷ Revenue | +3.7% | +12.0% | -6.4% | +7.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +25.6% | +21.2% | +7.6% | +18.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +142.9% | — | -49.8% | +21.9% |
Valuation Metrics
ACHC leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 29.8x trailing earnings, ENSG trades at a 93% valuation discount to LFST's 442.5x P/E. Adjusting for growth (PEG ratio), BTSG offers better value at 1.25x vs ENSG's 2.16x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $10.2B | $3.4B | $2.3B | $10.2B |
| Enterprise ValueMkt cap + debt − cash | $13.0B | $3.4B | $4.8B | $13.8B |
| Trailing P/EPrice ÷ TTM EPS | 60.85x | 442.50x | -2.01x | 29.85x |
| Forward P/EPrice ÷ next-FY EPS est. | 34.00x | 121.07x | 16.42x | 23.19x |
| PEG RatioP/E ÷ EPS growth rate | 1.25x | — | — | 2.16x |
| EV / EBITDAEnterprise value multiple | 22.68x | 41.98x | 8.27x | 25.71x |
| Price / SalesMarket cap ÷ Revenue | 0.79x | 2.41x | 0.68x | 2.01x |
| Price / BookPrice ÷ Book value/share | 6.17x | 2.28x | 1.04x | 4.59x |
| Price / FCFMarket cap ÷ FCF | 25.91x | 31.20x | — | 27.46x |
Profitability & Efficiency
Evenly matched — LFST and ENSG each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
BTSG delivers a 16.7% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-41 for ACHC. LFST carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to ENSG's 1.86x. On the Piotroski fundamental quality scale (0–9), BTSG scores 7/9 vs ENSG's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +16.7% | +1.6% | -40.9% | +16.6% |
| ROA (TTM)Return on assets | +5.0% | +1.1% | -18.6% | +6.8% |
| ROICReturn on invested capital | +6.7% | +1.2% | +5.9% | +7.0% |
| ROCEReturn on capital employed | +9.0% | +1.3% | +7.5% | +10.2% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 5 | 5 |
| Debt / EquityFinancial leverage | 1.51x | 0.13x | 1.24x | 1.86x |
| Net DebtTotal debt minus cash | $2.8B | -$55M | $2.5B | $3.7B |
| Cash & Equiv.Liquid assets | $88M | $249M | $133M | $504M |
| Total DebtShort + long-term debt | $2.8B | $194M | $2.7B | $4.2B |
| Interest CoverageEBIT ÷ Interest expense | 2.13x | 3.30x | -5.99x | 88.33x |
Total Returns (Dividends Reinvested)
BTSG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BTSG five years ago would be worth $48,127 today (with dividends reinvested), compared to $3,823 for ACHC. Over the past 12 months, BTSG leads with a +129.8% total return vs ACHC's +1.2%. The 3-year compound annual growth rate (CAGR) favors BTSG at 68.8% vs ACHC's -29.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +37.9% | +27.2% | +71.2% | +0.3% |
| 1-Year ReturnPast 12 months | +129.8% | +60.6% | +1.2% | +27.5% |
| 3-Year ReturnCumulative with dividends | +381.3% | +4.1% | -64.5% | +88.9% |
| 5-Year ReturnCumulative with dividends | +381.3% | -59.6% | -61.8% | +103.2% |
| 10-Year ReturnCumulative with dividends | +381.3% | -59.6% | -58.5% | +752.0% |
| CAGR (3Y)Annualised 3-year return | +68.8% | +1.4% | -29.2% | +23.6% |
Risk & Volatility
Evenly matched — LFST and ENSG each lead in 1 of 2 comparable metrics.
Risk & Volatility
ENSG is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than BTSG's 1.46 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LFST currently trades 99.6% from its 52-week high vs ENSG's 80.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.46x | 1.20x | 0.84x | 0.42x |
| 52-Week HighHighest price in past year | $54.68 | $8.89 | $30.20 | $218.00 |
| 52-Week LowLowest price in past year | $19.01 | $3.74 | $11.43 | $133.81 |
| % of 52W HighCurrent price vs 52-week peak | +96.8% | +99.6% | +81.0% | +80.0% |
| RSI (14)Momentum oscillator 0–100 | 67.9 | 60.4 | 46.2 | 23.3 |
| Avg Volume (50D)Average daily shares traded | 3.0M | 2.9M | 3.1M | 358K |
Analyst Outlook
ENSG leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: BTSG as "Buy", LFST as "Buy", ACHC as "Buy", ENSG as "Buy". Consensus price targets imply 27.6% upside for ENSG (target: $222) vs -7.9% for BTSG (target: $49). ENSG is the only dividend payer here at 0.14% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $48.75 | $9.30 | $23.50 | $222.33 |
| # AnalystsCovering analysts | 9 | 11 | 25 | 13 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +0.1% |
| Dividend StreakConsecutive years of raises | — | — | 1 | 12 |
| Dividend / ShareAnnual DPS | — | — | — | $0.24 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.4% | 0.0% | +2.2% | +0.2% |
ACHC leads in 1 of 6 categories (Valuation Metrics). BTSG leads in 1 (Total Returns). 3 tied.
BTSG vs LFST vs ACHC vs ENSG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BTSG or LFST or ACHC or ENSG a better buy right now?
For growth investors, The Ensign Group, Inc.
(ENSG) is the stronger pick with 18. 7% revenue growth year-over-year, versus 5. 0% for Acadia Healthcare Company, Inc. (ACHC). The Ensign Group, Inc. (ENSG) offers the better valuation at 29. 8x trailing P/E (23. 2x forward), making it the more compelling value choice. Analysts rate BrightSpring Health Services, Inc. Common Stock (BTSG) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BTSG or LFST or ACHC or ENSG?
On trailing P/E, The Ensign Group, Inc.
(ENSG) is the cheapest at 29. 8x versus LifeStance Health Group, Inc. at 442. 5x. On forward P/E, Acadia Healthcare Company, Inc. is actually cheaper at 16. 4x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: BrightSpring Health Services, Inc. Common Stock wins at 0. 70x versus The Ensign Group, Inc. 's 1. 68x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BTSG or LFST or ACHC or ENSG?
Over the past 5 years, BrightSpring Health Services, Inc.
Common Stock (BTSG) delivered a total return of +381. 3%, compared to -61. 8% for Acadia Healthcare Company, Inc. (ACHC). Over 10 years, the gap is even starker: ENSG returned +752. 0% versus LFST's -59. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BTSG or LFST or ACHC or ENSG?
By beta (market sensitivity over 5 years), The Ensign Group, Inc.
(ENSG) is the lower-risk stock at 0. 42β versus BrightSpring Health Services, Inc. Common Stock's 1. 46β — meaning BTSG is approximately 247% more volatile than ENSG relative to the S&P 500. On balance sheet safety, LifeStance Health Group, Inc. (LFST) carries a lower debt/equity ratio of 13% versus 186% for The Ensign Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BTSG or LFST or ACHC or ENSG?
By revenue growth (latest reported year), The Ensign Group, Inc.
(ENSG) is pulling ahead at 18. 7% versus 5. 0% for Acadia Healthcare Company, Inc. (ACHC). On earnings-per-share growth, the picture is similar: BrightSpring Health Services, Inc. Common Stock grew EPS 1029% year-over-year, compared to -537. 4% for Acadia Healthcare Company, Inc.. Over a 3-year CAGR, BTSG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BTSG or LFST or ACHC or ENSG?
The Ensign Group, Inc.
(ENSG) is the more profitable company, earning 6. 8% net margin versus -33. 3% for Acadia Healthcare Company, Inc. — meaning it keeps 6. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACHC leads at 11. 7% versus 1. 8% for LFST. At the gross margin level — before operating expenses — LFST leads at 28. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BTSG or LFST or ACHC or ENSG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, BrightSpring Health Services, Inc. Common Stock (BTSG) is the more undervalued stock at a PEG of 0. 70x versus The Ensign Group, Inc. 's 1. 68x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Acadia Healthcare Company, Inc. (ACHC) trades at 16. 4x forward P/E versus 121. 1x for LifeStance Health Group, Inc. — 104. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ENSG: 27. 6% to $222. 33.
08Which pays a better dividend — BTSG or LFST or ACHC or ENSG?
In this comparison, ENSG (0.
1% yield) pays a dividend. BTSG, LFST, ACHC do not pay a meaningful dividend and should not be held primarily for income.
09Is BTSG or LFST or ACHC or ENSG better for a retirement portfolio?
For long-horizon retirement investors, The Ensign Group, Inc.
(ENSG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), +752. 0% 10Y return). Both have compounded well over 10 years (ENSG: +752. 0%, LFST: -59. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BTSG and LFST and ACHC and ENSG?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BTSG is a mid-cap quality compounder stock; LFST is a small-cap quality compounder stock; ACHC is a small-cap quality compounder stock; ENSG is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.